Digital chronic care company Omada reported a quarterly profit for the first time
since going public
less than a year ago, the company revealed while announcing its full year 2025 earnings Thursday.
Omada also provided earnings guidance for 2026, suggesting the company will continue to grow as it capitalizes on the demand for popular GLP-1 obesity medications.
Omada earned $260 million in revenue in 2025, 53% more than the year before — above top-end preliminary results the company
announced
at the J.P. Morgan Healthcare Conference in January. In August, shortly after it went public, it
projected
top-end earnings of $241 million for the year.
Continue to STAT+ to read the full story…
— Source: STAT News (https://www.statnews.com/2026/03/05/omada-reports-quarterly-profit-glp1-opportunity/)
